Lundbeck and its companion Otsuka are no more in conversations with the FDA relating to authorization of Rexulti for the therapy of PTSD complying with a denial by the medication firm in September.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/lundbeck-abandons-plans-for-ptsd-drug-approval-after-rejection-from-fda/